Fountain Life Named Longevity Clinic of the Year for Second Consecutive Year

Recognized by peers at the Roundtable of Longevity Clinics, the 2026 award honors Fountain Life's leadership in data-driven longevity medicine, supported by more than 15 billion clinical data points and measurable Member outcomes.

ORLANDO, Fla., Oct. 21, 2026 /PRNewswire/ -- Fountain Life, an award-winning longevity leader transforming healthcare through early disease detection, precision diagnostics, and healthspan optimization, has been named Longevity Clinic of the Year 2026 by the Roundtable of Longevity Clinics. It is the second consecutive year the company has received the award.

Voted on by longevity medicine leaders and experts, the award recognizes Fountain Life's work translating longevity science into proactive, personalized care. It was presented in conjunction with the Roundtable at the Buck Institute for Research on Aging in Novato, California.

"Accepting this award on behalf of Fountain Life was a proud moment. To be named Longevity Clinic of the Year by our peers for the second consecutive year is a meaningful recognition of our team's dedication to advancing precision medicine," said Dr. Dawn Mussallem, Chief Medical Officer of Fountain Life. "Above all, it reflects the purpose behind our work: helping our Members live longer, healthier, more fulfilling lives."

Advancing Proactive Healthcare

Fountain Life's model combines advanced diagnostics, ongoing health tracking, and personalized interventions to help physicians identify risks earlier and measure changes over time.

"What distinguishes Fountain Life is its ability to move beyond one-time diagnostic testing to continuously measure health, identify disease earlier, and evaluate the impact of personalized interventions over time," said Dr. Dawn Mussallem, Chief Medical Officer of Fountain Life.

The company's longitudinal dataset includes more than 15 billion clinical data points from over 8,000 Members. Its findings include:

• Cardiovascular health: 88% of Members show early signs of coronary plaque; 26% halt plaque progression and 6% experience regression.
• Metabolic health: 51% of Members with prediabetes return to normal blood sugar levels in an average of 1.2 years; 64% of Members with diabetes improve to healthier metabolic ranges.
• Liver health: Follow-up MRI confirms resolution in 52% of fatty liver cases.
• Brain health: Nearly one in four Members show accelerated brain aging at baseline; 46% improve on follow-up measures.
• Cancer detection: Early cancer signals are identified in up to 3.4% of Members.

Turning Data into Personalized Care

Fountain Life memberships combine AI-Guided Diagnostics, the Zori AI Medical Expert, Restorative Therapeutics, and Always-on Care. Testing can include full-body and brain MRI, coronary plaque analysis, whole genome sequencing, biological age profiling, more than 100 blood biomarkers, microbiome analysis, VO₂ max testing, and functional movement assessments. Additional options include multi-cancer early detection, neurocognitive testing, and nutritional, mitochondrial, environmental toxin, and immune longevity assessments.

Together, these technologies can generate more than 150 GB of health data per Member. Zori AI helps physicians connect findings across diagnostic modalities and tailor health optimization plans. Members also receive physician-led guidance, ongoing monitoring, and access to a dedicated care team and advanced therapeutics.

Expanding Nationwide

Fountain Life operates centers in New York, Naples, Orlando, Dallas, and Houston, with locations in Los Angeles and Miami coming soon.

About Fountain Life
Fountain Life is a leading longevity brand committed to helping people not only live longer but live better. By combining cutting-edge science, advanced AI-guided diagnostics, and restorative therapeutics, Fountain Life delivers a next-generation preventive health model. This approach integrates regenerative medicine and AI-driven health intelligence to detect disease early, optimize performance, and extend healthspan.

Founded in 2020 by pioneering leaders in business, medicine, and innovation Dr. Peter Diamandis, Tony Robbins, Dr. Robert Hariri and Dr. William Kapp Fountain Life was established to fill a critical void in healthcare: the absence of proactive, data-driven care that emphasizes prevention, optimization, and the extension of both healthspan and lifespan.

In 2025 and again in 2026, Fountain Life was named Longevity Brand of the Year, underscoring its leadership in premium preventive healthcare and healthspan optimization. That same year, Zori AI, Fountain Life's proprietary intelligence engine was recognized with a Global Tech Award, celebrating its breakthrough role in AI-powered health intelligence and personalized longevity guidance.

Through its tiered membership programs CORE, APEX, and APEX FAMILY, Fountain Life delivers scalable access to this groundbreaking model. At the heart of the experience is Zori AI, which synthesizes each member's comprehensive health data to uncover hidden risks and provide highly personalized recommendations.

These insights are implemented through a dedicated care team and on-demand virtual care, ensuring ongoing support and precision delivery. Fountain Life is redefining the future of medicine, available now. To learn more or to take control of your health, visit www.fountainlife.com.

SOURCE Fountain Life